Lonza | LONN - Assets


Lonza reported CHF18.97B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Akzo Nobel EUR 13.95B 55M Dec/2025
Alcon AG USD 31.56B 31M Dec/2025
Almirall EUR 2.34B 29.21M Dec/2025
AstraZeneca USD 114.07B 382M Dec/2025
BASF EUR 76.17B 267M Dec/2025
Bayer EUR 104.54B 331M Dec/2025
Beiersdorf EUR 12.76B 166M Dec/2025
Covestro EUR 13.47B 245M Dec/2025
Demant DKK 39.07B 6.43B Dec/2025
Fresenius EUR 42.46B 1.14B Sep/2025
Fresenius Medical Care EUR 31B 115.33M Dec/2025
Geberit CHF 3.86B 252.6M Dec/2025
Genmab DKK 12.87B 5.85B Dec/2025
Givaudan CHF 11.86B 587M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
GN Store Nord DKK 29.23B 170M Dec/2025
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Johnson Matthey GBP 5.83B 362M Dec/2025
Merck EUR 51.53B 600M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
Philips EUR 26.94B 605M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Sika AG CHF 15.15B 245M Dec/2025
Smith & Nephew USD 10.69B 150M Dec/2025
Solvay EUR 6.15B 173M Dec/2025
UCB EUR 18.16B 971M Dec/2025